Evercore ISI Downgrades CRISPR Therapeutics (CRSP) to In Line
Tweet Send to a Friend
Evercore ISI analyst Liisa Bayko downgraded CRISPR Therapeutics (NASDAQ: CRSP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
